It shall be noticed, that in men, approximately 5% of testosterone undergoes 5α-reduction to form the more potent androgen, dihydrotestosterone (DHT), also known as androstanolone. From another side approximately % of testosterone is converted into estradiol (the primary female sex hormone) by aromatase an enzyme expressed in the brain, liver, and adipose tissues. Hence, don`t forget to take precautions to avoid respective side effects. Thereof we recommend to perform blood works and take aromatase inhibitors on cycle (if required, anastrozole preferably) and SERMs (clomifene, toremifene) during post cycle therapy (PCT).
* Testosterone-Propionate is optimal but Testosterone-Cypionate or Testosterone-Enanthate can be used if the Propionate is a problem for you.
* Trenbolone-Acetate will really set this cycle off more so than any steroid in the stack. If you respond poorly to the hormone you might replace it with Masteron-Propionate at a dosing of 300mg per week; three injections of 100mg each.
* While Equipoise on its own is not a great mass builder, coupled with Testosterone-Propionate and the initial Dianabol use you will produce some very solid gains and see your strength increase very nicely. Further, EQ will promote a more conditioned look while you’re still growing.
* Arimidex may not be needed for some but most will be best served with this low dose. If aromatase related side-effects become a problem you will need to increase the dose to 1mg/eod and in most all men this will eliminate the problems.
* How much weight can you gain from this cycle? That’s a hard question to answer; it will greatly depend on how high your calorie intake is. If you are eating a maintenance level diet you may be able to put on 7-10lbs of tissue, this is excluding any water weight that might come with the Dianabol but any water weight will dissipate shortly after it’s discontinued. Further, the Arimidex will greatly help control this issue. Moreover, the higher your carb intake is above necessity the more water you’ll probably hold.
Although deaths from methadone are on the rise, methadone-associated deaths are not being caused primarily by methadone intended for methadone treatment programs, according to a panel of experts convened by the Substance Abuse and Mental Health Services Administration , which released a report titled "Methadone-Associated Mortality, Report of a National Assessment". The consensus report concludes that "although the data remains incomplete, National Assessment meeting participants concurred that methadone tablets or diskettes distributed through channels other than opioid treatment programs most likely are the central factors in methadone-associated mortality."